| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Esophageal Atresia | 2 | 2018 | 24 | 1.42 | Why? |
| Abnormalities, Multiple | 3 | 2018 | 75 | 1.18 | Why? |
| Respiratory Distress Syndrome, Newborn | 2 | 2019 | 124 | 0.86 | Why? |
| Heart Defects, Congenital | 3 | 2018 | 933 | 0.79 | Why? |
| Arthritis, Juvenile | 2 | 2019 | 191 | 0.78 | Why? |
| Recreation | 1 | 2020 | 143 | 0.77 | Why? |
| Child Welfare | 3 | 2021 | 405 | 0.76 | Why? |
| Ductus Arteriosus | 1 | 2018 | 4 | 0.74 | Why? |
| Neurofibromatosis 1 | 1 | 2018 | 19 | 0.73 | Why? |
| Familial Mediterranean Fever | 1 | 2019 | 88 | 0.73 | Why? |
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 54 | 0.73 | Why? |
| Methemoglobinemia | 1 | 2019 | 51 | 0.72 | Why? |
| Cultured Milk Products | 1 | 2017 | 3 | 0.72 | Why? |
| Self Administration | 1 | 2018 | 125 | 0.72 | Why? |
| Social Problems | 1 | 2018 | 77 | 0.72 | Why? |
| Lactobacillus paracasei | 1 | 2017 | 5 | 0.72 | Why? |
| Limb Deformities, Congenital | 1 | 2018 | 35 | 0.71 | Why? |
| Neonatal Sepsis | 1 | 2019 | 69 | 0.71 | Why? |
| Azygos Vein | 1 | 2017 | 2 | 0.71 | Why? |
| Arteriovenous Fistula | 1 | 2017 | 23 | 0.68 | Why? |
| Heart Septal Defects, Ventricular | 1 | 2017 | 33 | 0.67 | Why? |
| Mucocutaneous Lymph Node Syndrome | 5 | 2020 | 1645 | 0.67 | Why? |
| Thoracotomy | 1 | 2017 | 85 | 0.67 | Why? |
| Ultrasonography, Prenatal | 2 | 2018 | 471 | 0.66 | Why? |
| Human Growth Hormone | 1 | 2018 | 120 | 0.66 | Why? |
| Milk | 2 | 2017 | 158 | 0.65 | Why? |
| Cardiovascular Abnormalities | 1 | 2017 | 72 | 0.65 | Why? |
| Analgesics, Non-Narcotic | 1 | 2018 | 164 | 0.64 | Why? |
| Behavior, Addictive | 2 | 2021 | 535 | 0.63 | Why? |
| Bullying | 1 | 2018 | 98 | 0.63 | Why? |
| Esophagus | 1 | 2018 | 139 | 0.62 | Why? |
| Coronary Vessel Anomalies | 1 | 2017 | 87 | 0.60 | Why? |
| Comparative Genomic Hybridization | 2 | 2011 | 33 | 0.60 | Why? |
| Crime Victims | 1 | 2018 | 148 | 0.59 | Why? |
| Gambling | 1 | 2018 | 183 | 0.58 | Why? |
| Epstein-Barr Virus Infections | 1 | 2019 | 366 | 0.58 | Why? |
| Diabetes, Gestational | 2 | 2019 | 426 | 0.58 | Why? |
| Acetaminophen | 1 | 2018 | 326 | 0.57 | Why? |
| Spine | 1 | 2018 | 292 | 0.57 | Why? |
| Aorta, Thoracic | 1 | 2017 | 271 | 0.56 | Why? |
| Anal Canal | 1 | 2018 | 367 | 0.56 | Why? |
| Infant, Newborn | 20 | 2021 | 23105 | 0.55 | Why? |
| Prenatal Exposure Delayed Effects | 1 | 2018 | 319 | 0.52 | Why? |
| Genetic Predisposition to Disease | 2 | 2018 | 4027 | 0.50 | Why? |
| Adolescent Behavior | 1 | 2018 | 400 | 0.49 | Why? |
| Osteochondrodysplasias | 1 | 2012 | 7 | 0.49 | Why? |
| Trachea | 1 | 2018 | 894 | 0.49 | Why? |
| Mental Retardation, X-Linked | 1 | 2011 | 4 | 0.49 | Why? |
| Chromosome Duplication | 1 | 2011 | 6 | 0.48 | Why? |
| Chromosomes, Human, Pair 6 | 1 | 2011 | 14 | 0.48 | Why? |
| X Chromosome Inactivation | 1 | 2011 | 23 | 0.48 | Why? |
| Mutation, Missense | 1 | 2018 | 863 | 0.47 | Why? |
| Eye Abnormalities | 1 | 2011 | 29 | 0.47 | Why? |
| Down Syndrome | 1 | 2017 | 397 | 0.47 | Why? |
| Chromosome Deletion | 1 | 2011 | 62 | 0.46 | Why? |
| Pediatrics | 8 | 2020 | 2969 | 0.46 | Why? |
| Bibliometrics | 1 | 2019 | 731 | 0.45 | Why? |
| Chromosomes, Human, X | 1 | 2011 | 81 | 0.45 | Why? |
| Ventricular Dysfunction, Right | 1 | 2018 | 639 | 0.41 | Why? |
| Congenital Abnormalities | 1 | 2012 | 170 | 0.41 | Why? |
| Smartphone | 1 | 2021 | 1840 | 0.40 | Why? |
| Publishing | 1 | 2019 | 990 | 0.39 | Why? |
| Consensus | 3 | 2021 | 6345 | 0.38 | Why? |
| Vitamins | 1 | 2018 | 1208 | 0.37 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.37 | Why? |
| Drug Delivery Systems | 1 | 2018 | 1365 | 0.37 | Why? |
| Cardiomyopathies | 1 | 2018 | 997 | 0.36 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.35 | Why? |
| Eye | 1 | 2011 | 374 | 0.34 | Why? |
| Heart | 1 | 2017 | 1791 | 0.33 | Why? |
| Genetic Association Studies | 3 | 2018 | 559 | 0.32 | Why? |
| Periodicals as Topic | 1 | 2019 | 1492 | 0.31 | Why? |
| Immunoglobulins, Intravenous | 4 | 2018 | 2705 | 0.30 | Why? |
| Dietary Supplements | 1 | 2018 | 2251 | 0.30 | Why? |
| Intensive Care Units, Neonatal | 4 | 2019 | 749 | 0.29 | Why? |
| Child | 23 | 2021 | 70012 | 0.28 | Why? |
| Italy | 17 | 2021 | 38444 | 0.28 | Why? |
| Vitamin D Deficiency | 1 | 2018 | 1782 | 0.27 | Why? |
| Social Isolation | 2 | 2021 | 5932 | 0.27 | Why? |
| Child, Preschool | 14 | 2021 | 36283 | 0.26 | Why? |
| Child Development | 2 | 2018 | 352 | 0.26 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.26 | Why? |
| Disease Transmission, Infectious | 3 | 2021 | 9044 | 0.25 | Why? |
| Gestational Age | 2 | 2019 | 1488 | 0.24 | Why? |
| Prenatal Diagnosis | 2 | 2018 | 345 | 0.24 | Why? |
| Vitamin D | 1 | 2018 | 2904 | 0.24 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.23 | Why? |
| Social Media | 4 | 2021 | 5798 | 0.21 | Why? |
| Societies, Medical | 8 | 2021 | 6907 | 0.21 | Why? |
| Epilepsy, Benign Neonatal | 1 | 2019 | 1 | 0.20 | Why? |
| KCNQ3 Potassium Channel | 1 | 2019 | 1 | 0.20 | Why? |
| Diagnosis, Differential | 4 | 2019 | 7220 | 0.20 | Why? |
| Child Health | 2 | 2021 | 940 | 0.20 | Why? |
| Exercise | 1 | 2020 | 6771 | 0.20 | Why? |
| Antibodies, Monoclonal | 1 | 2019 | 8041 | 0.20 | Why? |
| Epileptic Syndromes | 1 | 2019 | 11 | 0.20 | Why? |
| Adolescent | 14 | 2021 | 86841 | 0.20 | Why? |
| Aid to Families with Dependent Children | 1 | 2018 | 1 | 0.20 | Why? |
| Female | 34 | 2021 | 380317 | 0.19 | Why? |
| Seizures | 2 | 2018 | 1163 | 0.19 | Why? |
| Genes, Neurofibromatosis 1 | 1 | 2018 | 3 | 0.19 | Why? |
| Humans | 57 | 2021 | 930598 | 0.19 | Why? |
| Infant | 13 | 2021 | 30274 | 0.19 | Why? |
| Heart Murmurs | 1 | 2018 | 4 | 0.19 | Why? |
| Pulmonary Valve Stenosis | 1 | 2018 | 15 | 0.18 | Why? |
| Enterocolitis, Necrotizing | 1 | 2018 | 71 | 0.18 | Why? |
| Megalencephaly | 1 | 2017 | 3 | 0.18 | Why? |
| Diet, Vegan | 1 | 2017 | 4 | 0.18 | Why? |
| Remission Induction | 2 | 2019 | 950 | 0.18 | Why? |
| Cyanosis | 1 | 2019 | 100 | 0.18 | Why? |
| Ribs | 1 | 2017 | 8 | 0.18 | Why? |
| Otitis | 1 | 2017 | 12 | 0.18 | Why? |
| Teratoma | 1 | 2017 | 25 | 0.17 | Why? |
| Dipodascus | 1 | 2017 | 1 | 0.17 | Why? |
| Growth Disorders | 1 | 2018 | 91 | 0.17 | Why? |
| Oxidative Stress | 2 | 2019 | 2050 | 0.17 | Why? |
| Masks | 1 | 2020 | 8528 | 0.17 | Why? |
| Sublingual Immunotherapy | 1 | 2018 | 88 | 0.17 | Why? |
| Diet, Vegetarian | 1 | 2017 | 31 | 0.17 | Why? |
| Vena Cava, Superior | 1 | 2017 | 30 | 0.17 | Why? |
| Defensins | 1 | 2017 | 64 | 0.17 | Why? |
| Intussusception | 1 | 2018 | 102 | 0.17 | Why? |
| Social Welfare | 1 | 2018 | 141 | 0.17 | Why? |
| Infection Control | 3 | 2021 | 23131 | 0.17 | Why? |
| Tracheitis | 1 | 2017 | 43 | 0.17 | Why? |
| Practice Guidelines as Topic | 5 | 2020 | 15421 | 0.16 | Why? |
| Oligosaccharides | 1 | 2017 | 69 | 0.16 | Why? |
| Dapsone | 1 | 2017 | 59 | 0.16 | Why? |
| Fermentation | 1 | 2017 | 156 | 0.16 | Why? |
| Male | 27 | 2021 | 367725 | 0.16 | Why? |
| Surface-Active Agents | 1 | 2019 | 267 | 0.16 | Why? |
| Infant Formula | 1 | 2017 | 64 | 0.16 | Why? |
| School Health Services | 1 | 2021 | 294 | 0.16 | Why? |
| HMGB1 Protein | 1 | 2019 | 223 | 0.16 | Why? |
| Infant, Premature | 2 | 2019 | 883 | 0.16 | Why? |
| Television | 1 | 2018 | 224 | 0.16 | Why? |
| Self Medication | 1 | 2018 | 131 | 0.16 | Why? |
| Postural Balance | 1 | 2017 | 144 | 0.16 | Why? |
| Injections, Subcutaneous | 1 | 2018 | 647 | 0.16 | Why? |
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2017 | 82 | 0.16 | Why? |
| Prognosis | 6 | 2019 | 32490 | 0.16 | Why? |
| Computers, Handheld | 1 | 2018 | 242 | 0.16 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.15 | Why? |
| Guidelines as Topic | 2 | 2020 | 2844 | 0.15 | Why? |
| Rotavirus Vaccines | 1 | 2018 | 203 | 0.15 | Why? |
| Arthritis, Infectious | 1 | 2017 | 111 | 0.15 | Why? |
| Antimicrobial Cationic Peptides | 1 | 2017 | 159 | 0.15 | Why? |
| Enteral Nutrition | 1 | 2019 | 320 | 0.15 | Why? |
| Drug Resistance | 1 | 2018 | 395 | 0.15 | Why? |
| Gastroenteritis | 2 | 2018 | 489 | 0.15 | Why? |
| Pemphigoid, Bullous | 1 | 2017 | 89 | 0.15 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.15 | Why? |
| Whole Exome Sequencing | 1 | 2017 | 437 | 0.15 | Why? |
| Intestinal Diseases | 1 | 2018 | 231 | 0.15 | Why? |
| Fetal Blood | 1 | 2019 | 573 | 0.14 | Why? |
| Blood Gas Analysis | 1 | 2019 | 893 | 0.14 | Why? |
| Ultrasonography, Doppler | 1 | 2018 | 406 | 0.14 | Why? |
| Sample Size | 1 | 2017 | 518 | 0.14 | Why? |
| Psychological Trauma | 1 | 2021 | 363 | 0.14 | Why? |
| Risk-Taking | 1 | 2018 | 508 | 0.14 | Why? |
| Neonatal Screening | 1 | 2017 | 285 | 0.14 | Why? |
| Polyphenols | 1 | 2018 | 283 | 0.14 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.13 | Why? |
| Domestic Violence | 1 | 2021 | 522 | 0.13 | Why? |
| Syndrome | 2 | 2012 | 1310 | 0.13 | Why? |
| Mandatory Programs | 1 | 2018 | 291 | 0.13 | Why? |
| Cerebrovascular Circulation | 1 | 2017 | 340 | 0.13 | Why? |
| Physical Fitness | 1 | 2017 | 334 | 0.13 | Why? |
| Risk Assessment | 7 | 2018 | 25439 | 0.13 | Why? |
| Immunization Schedule | 1 | 2021 | 1305 | 0.13 | Why? |
| Vasoconstrictor Agents | 1 | 2018 | 714 | 0.13 | Why? |
| Hospital Mortality | 1 | 2018 | 22087 | 0.13 | Why? |
| Electrocardiography | 2 | 2018 | 3957 | 0.13 | Why? |
| Diet, Mediterranean | 1 | 2018 | 351 | 0.13 | Why? |
| Dysostoses | 1 | 2012 | 3 | 0.13 | Why? |
| Developmental Disabilities | 2 | 2018 | 257 | 0.12 | Why? |
| Echocardiography | 2 | 2017 | 3661 | 0.12 | Why? |
| Pharyngitis | 1 | 2017 | 687 | 0.12 | Why? |
| Breast Feeding | 2 | 2021 | 1585 | 0.12 | Why? |
| Desensitization, Immunologic | 1 | 2018 | 574 | 0.12 | Why? |
| Sex Chromosome Aberrations | 1 | 2011 | 4 | 0.12 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.12 | Why? |
| Appointments and Schedules | 1 | 2021 | 1204 | 0.12 | Why? |
| Cattle | 1 | 2017 | 1336 | 0.12 | Why? |
| Karyotype | 1 | 2011 | 16 | 0.12 | Why? |
| Food Hypersensitivity | 1 | 2018 | 397 | 0.12 | Why? |
| Weight Gain | 1 | 2017 | 552 | 0.11 | Why? |
| Ovarian Neoplasms | 1 | 2017 | 465 | 0.11 | Why? |
| Cohort Studies | 4 | 2019 | 36005 | 0.11 | Why? |
| Retrospective Studies | 7 | 2019 | 105322 | 0.11 | Why? |
| Internet | 2 | 2020 | 6204 | 0.11 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2011 | 207 | 0.11 | Why? |
| Case-Control Studies | 3 | 2019 | 17671 | 0.11 | Why? |
| Forkhead Transcription Factors | 1 | 2011 | 231 | 0.10 | Why? |
| Mycoses | 1 | 2017 | 589 | 0.10 | Why? |
| Continuous Positive Airway Pressure | 1 | 2019 | 1187 | 0.10 | Why? |
| Pregnancy | 5 | 2019 | 23879 | 0.10 | Why? |
| Rhinitis | 1 | 2017 | 626 | 0.10 | Why? |
| Program Evaluation | 1 | 2018 | 1929 | 0.10 | Why? |
| Lung Injury | 1 | 2019 | 919 | 0.10 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.10 | Why? |
| Delivery, Obstetric | 1 | 2019 | 1292 | 0.10 | Why? |
| Coronary Vessels | 1 | 2017 | 914 | 0.10 | Why? |
| Equipment Design | 1 | 2020 | 3095 | 0.10 | Why? |
| Probiotics | 1 | 2017 | 694 | 0.10 | Why? |
| Exanthema | 1 | 2019 | 1097 | 0.10 | Why? |
| Genetic Counseling | 1 | 2012 | 229 | 0.10 | Why? |
| Self Report | 1 | 2021 | 3802 | 0.09 | Why? |
| Double-Blind Method | 2 | 2017 | 5988 | 0.09 | Why? |
| Mental Disorders | 1 | 2011 | 6742 | 0.09 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.09 | Why? |
| Patient Compliance | 1 | 2018 | 1468 | 0.09 | Why? |
| Milk, Human | 1 | 2017 | 956 | 0.09 | Why? |
| Sicily | 2 | 2018 | 153 | 0.09 | Why? |
| Hypersensitivity | 1 | 2018 | 1137 | 0.09 | Why? |
| Needs Assessment | 1 | 2018 | 2352 | 0.08 | Why? |
| Premature Birth | 1 | 2019 | 2151 | 0.08 | Why? |
| Family | 1 | 2021 | 2909 | 0.08 | Why? |
| Methylprednisolone | 1 | 2017 | 2107 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2021 | 243684 | 0.08 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2017 | 1380 | 0.07 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.07 | Why? |
| Immunoglobulin A | 1 | 2017 | 3567 | 0.07 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Antimalarials | 1 | 2017 | 2505 | 0.07 | Why? |
| Parents | 1 | 2018 | 2758 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
| Hypoxia | 1 | 2019 | 3626 | 0.07 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.07 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.06 | Why? |
| Feces | 1 | 2017 | 4235 | 0.06 | Why? |
| Reactive Oxygen Species | 2 | 2019 | 1136 | 0.06 | Why? |
| Influenza Vaccines | 1 | 2019 | 2941 | 0.06 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.06 | Why? |
| Age Factors | 3 | 2018 | 21039 | 0.06 | Why? |
| Protective Factors | 2 | 2018 | 1720 | 0.06 | Why? |
| Electroencephalography | 2 | 2019 | 1242 | 0.06 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.05 | Why? |
| Attitude of Health Personnel | 1 | 2019 | 4741 | 0.05 | Why? |
| Policy Making | 2 | 2018 | 829 | 0.05 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.05 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.05 | Why? |
| Birth Order | 1 | 2018 | 7 | 0.05 | Why? |
| Cervical Length Measurement | 1 | 2019 | 38 | 0.05 | Why? |
| Hepatomegaly | 1 | 2018 | 34 | 0.05 | Why? |
| Splenomegaly | 1 | 2018 | 43 | 0.05 | Why? |
| Young Adult | 3 | 2019 | 93724 | 0.05 | Why? |
| Thinness | 1 | 2019 | 99 | 0.05 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.05 | Why? |
| Neurophysiological Monitoring | 1 | 2018 | 58 | 0.05 | Why? |
| Marital Status | 1 | 2019 | 186 | 0.05 | Why? |
| Infant, Premature, Diseases | 1 | 2018 | 74 | 0.04 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.04 | Why? |
| Health Policy | 1 | 2018 | 6242 | 0.04 | Why? |
| Treatment Outcome | 3 | 2019 | 51732 | 0.04 | Why? |
| Hip Joint | 1 | 2017 | 59 | 0.04 | Why? |
| Risk Factors | 4 | 2019 | 71621 | 0.04 | Why? |
| Parent-Child Relations | 1 | 2021 | 384 | 0.04 | Why? |
| Hospitalization | 2 | 2018 | 54280 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 9335 | 0.04 | Why? |
| Bacterial Vaccines | 1 | 2018 | 139 | 0.04 | Why? |
| Nutritive Value | 1 | 2017 | 100 | 0.04 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.04 | Why? |
| Hand Strength | 1 | 2017 | 202 | 0.04 | Why? |
| Nutritional Requirements | 1 | 2017 | 115 | 0.04 | Why? |
| Labor, Obstetric | 1 | 2019 | 257 | 0.04 | Why? |
| Computers | 1 | 2017 | 199 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2017 | 6817 | 0.04 | Why? |
| Intestinal Obstruction | 1 | 2018 | 197 | 0.04 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.04 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.04 | Why? |
| Treatment Refusal | 1 | 2018 | 211 | 0.04 | Why? |
| Fetus | 1 | 2019 | 484 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2018 | 557 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2019 | 14232 | 0.03 | Why? |
| Off-Label Use | 1 | 2018 | 553 | 0.03 | Why? |
| Genome, Human | 1 | 2017 | 400 | 0.03 | Why? |
| State Government | 1 | 2018 | 416 | 0.03 | Why? |
| Hematologic Tests | 1 | 2018 | 521 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.03 | Why? |
| Anticonvulsants | 1 | 2018 | 634 | 0.03 | Why? |
| Adult | 4 | 2019 | 244371 | 0.03 | Why? |
| Abdominal Pain | 1 | 2018 | 858 | 0.03 | Why? |
| Social Behavior | 1 | 2020 | 882 | 0.03 | Why? |
| Public Health | 1 | 2018 | 16359 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2019 | 1316 | 0.03 | Why? |
| Europe | 2 | 2018 | 12702 | 0.03 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.03 | Why? |
| Psychiatric Status Rating Scales | 1 | 2017 | 1340 | 0.03 | Why? |
| Animals | 2 | 2017 | 78931 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2017 | 1887 | 0.02 | Why? |
| Mass Media | 1 | 2018 | 837 | 0.02 | Why? |
| Antioxidants | 1 | 2019 | 1593 | 0.02 | Why? |
| Medical Staff, Hospital | 1 | 2019 | 1258 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Surveys and Questionnaires | 3 | 2021 | 43792 | 0.02 | Why? |
| Pregnancy Complications | 1 | 2019 | 1388 | 0.02 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.02 | Why? |
| Resilience, Psychological | 1 | 2021 | 2329 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Oxygen | 1 | 2019 | 3715 | 0.02 | Why? |
| Nursing Staff, Hospital | 1 | 2019 | 1554 | 0.02 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.02 | Why? |
| Clinical Competence | 1 | 2019 | 3263 | 0.02 | Why? |
| Coronary Artery Disease | 1 | 2018 | 2570 | 0.02 | Why? |
| Middle Aged | 2 | 2019 | 270681 | 0.02 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Fever | 1 | 2018 | 7795 | 0.01 | Why? |
| United States | 2 | 2018 | 46150 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2018 | 48226 | 0.01 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.01 | Why? |
| Education, Distance | 1 | 2020 | 4956 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Obesity | 1 | 2019 | 7388 | 0.01 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.01 | Why? |
| Stress, Psychological | 1 | 2020 | 10231 | 0.01 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.01 | Why? |
| Viral Vaccines | 1 | 2018 | 7560 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2019 | 9706 | 0.01 | Why? |
| Biomarkers | 1 | 2019 | 23361 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2019 | 22116 | 0.01 | Why? |
| Health Personnel | 1 | 2019 | 29646 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2018 | 29620 | 0.01 | Why? |
| Aged | 1 | 2019 | 215776 | 0.00 | Why? |